ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity.
Nature. 2020 Mar;579(7797):130-135. doi: 10.1038/s41586-020-2015-4. Epub 2020 Feb 19.
Nature. 2020.
PMID: 32076273
Free PMC article.